Last update 01 Nov 2024

Inatherys SAS

Private Company|
2009|
France
|
< 10
|
www.inatherys.com

Overview

Basic Info

Introduction
Inatherys, a biotechnology company from academic research. Founded in 2009, Inatherys is a biotechnology company spin-off from INSERM. It is a biotechnology company developing monoclonal antibodies for therapies。

Tags

Neoplasms
Other Diseases
Immune System Diseases
Monoclonal antibody
Antibody drug conjugate (ADC)

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Hemic and Lymphatic Diseases1
Immune System Diseases1
Top 5 Drug TypeCount
Monoclonal antibody2
Antibody drug conjugate (ADC)1
Top 5 TargetCount
TfR1(Transferrin receptor protein 1)2
CD89(IgA Fc receptor)1

Related

3
Drugs associated with Inatherys SAS
INA-03
Target
TfR1
Mechanism
TfR1 antagonists
Active Org.
Institut Jean Paoli & Irene CalmettesInstitut Jean Paoli & Irene Calmettes [+1]
Originator Org.
Institut Jean Paoli & Irene CalmettesInstitut Jean Paoli & Irene Calmettes
Active Indication
Acute Lymphoblastic Leukemia [+5]
Inactive Indication
Acute Biphenotypic Leukemia
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
INA-01
Target
TfR1
Mechanism
TfR1 antagonists
Active Org.
Inatherys SAS
Originator Org.
Inatherys SAS
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
INA-02
Target
CD89
Mechanism
CD89 inhibitors
Active Org.
Inatherys SAS
Originator Org.
Inatherys SAS
Active Indication
Inflammation
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Inatherys SAS
NCT03957915 / RecruitingEarly Phase 1IIT
A Phase I, First in Human, Open-label Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia
100 Clinical Results associated with Inatherys SAS
Login to view more data
0 Patents (Medical) associated with Inatherys SAS
Login to view more data
100 Deals associated with Inatherys SAS
Login to view more data
100 Translational Medicine associated with Inatherys SAS
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 1 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
INA-03
 ( TfR1 )		Relapsing acute myeloid leukemia
More
Phase 1 Clinical
INA-02
 ( CD89 )		Inflammation
More
Preclinical
INA-01
 ( TfR1 )		Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free